当前位置:首页 - 行情中心 - 晨光生物(300138) - 财务分析 - 现金流量表

晨光生物

(300138)

  

流通市值:40.90亿  总市值:48.80亿
流通股本:4.46亿   总股本:5.33亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金7,105,883,164.864,990,270,391.893,584,900,786.671,863,278,504.59
收到的税费返还114,840,153.73100,392,231.8597,482,132.8960,500,155.79
收到其他与经营活动有关的现金200,850,679.41131,790,238.9597,119,767.9573,294,849.76
经营活动现金流入的平衡项目0000
经营活动现金流入小计7,421,573,9985,222,452,862.693,779,502,687.511,997,073,510.14
购买商品、接受劳务支付的现金7,485,391,728.33,806,653,510.112,808,244,339.91,974,123,601.8
支付给职工以及为职工支付的现金264,143,586.66199,373,406.07129,346,163.2170,261,043.66
支付的各项税费124,288,931.9792,493,638.5878,586,859.4733,053,824.01
支付其他与经营活动有关的现金136,218,923.76128,293,702.4380,760,860.9855,481,025.57
经营活动现金流出的平衡项目0000
经营活动现金流出小计8,010,043,170.694,226,814,257.193,096,938,223.562,132,919,495.04
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-588,469,172.69995,638,605.5682,564,463.95-135,845,984.9
二、投资活动产生的现金流量:
收回投资收到的现金118,863,442.35966,617,738.65653,543,783.55330,919,362.9
取得投资收益收到的现金77,561,964.6563,076,034.1249,556,372.138,009,388.79
处置固定资产、无形资产和其他长期资产收回的现金净额283,823.87332,711.23314,525.874,495
投资活动现金流入的平衡项目0000
投资活动现金流入小计196,709,230.871,030,026,484703,414,681.55338,933,246.69
购建固定资产、无形资产和其他长期资产支付的现金189,199,325.79142,361,947.4690,682,059.3227,127,732.24
投资支付的现金455,777,428.21905,984,439.5495,547,444.9238,297,534.5
支付其他与投资活动有关的现金---14,521.98
投资活动现金流出的平衡项目0000
投资活动现金流出小计644,976,7541,048,346,386.96586,229,504.22265,439,788.72
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-448,267,523.13-18,319,902.96117,185,177.3373,493,457.97
三、筹资活动产生的现金流量:
取得借款收到的现金4,677,667,378.72,588,703,439.91,526,983,439.9754,687,439.9
收到其他与筹资活动有关的现金498,939,000198,000,00048,000,00048,089,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计5,176,606,378.72,786,703,439.91,574,983,439.9802,776,439.9
偿还债务支付的现金3,379,969,305.562,128,698,888.891,249,498,888.89167,759,305.56
分配股利、利润或偿付利息支付的现金181,414,538.38147,865,357.99127,089,665.1321,903,003.13
支付其他与筹资活动有关的现金318,406,134220,980,000220,000,000220,060,696.22
筹资活动现金流出平衡项目0000
筹资活动现金流出小计3,879,789,977.942,497,544,246.881,596,588,554.02409,723,004.91
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额1,296,816,400.76289,159,193.02-21,605,114.12393,053,434.99
四、汇率变动对现金及现金等价物的影响-6,050,321.18-5,308,661.6534,315.2416,801.34
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额254,029,383.761,261,169,233.91778,178,842.36331,117,709.4
加:期初现金及现金等价物余额831,235,578.96831,235,578.96831,235,578.96831,235,578.96
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,085,264,962.722,092,404,812.871,609,414,421.321,162,353,288.36
补充资料:
净利润494,173,306.76-314,892,436.62-
资产减值准备-4,056,267.83--12,907,442.35-
固定资产和投资性房地产折旧144,428,199.51-61,349,333.26-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧144,428,199.51-61,349,333.26-
无形资产摊销8,115,719.32-4,190,506.41-
长期待摊费用摊销200,000.04-100,000.02-
处置固定资产、无形资产和其他长期资产的损失632,753-1,551.18-
固定资产报废损失1,102,030.14-858,664.76-
公允价值变动损失-5,363,332.98--6,583,420.53-
财务费用70,091,151.09-42,128,967.66-
投资损失-68,655,795.66--47,643,119.39-
递延所得税-8,603,640.79-6,500,351.57-
其中:递延所得税资产减少-8,601,758.19-5,981,402.53-
递延所得税负债增加-1,882.6-518,949.04-
存货的减少-1,145,375,047.35-319,571,994.14-
经营性应收项目的减少135,235,688.81-285,339,718.28-
经营性应付项目的增加-211,804,447.51--285,918,649.67-
现金的期末余额875,264,962.72-1,319,414,421.32-
减:现金的期初余额601,235,578.96-601,235,578.96-
加:现金等价物的期末余额210,000,000-290,000,000-
减:现金等价物的期初余额230,000,000-230,000,000-
公告日期2024-04-182023-10-242023-08-142023-04-26
审计意见(境内)标准无保留意见
TOP↑